Elizabeth Blackburn: Because science is worth it
نویسندگان
چکیده
منابع مشابه
Elizabeth Blackburn: Because science is worth it
E lizabeth Blackburn is the leading lady of telomere biology. Her discovery of telomerase with her graduate student Carol Greider in 1985 revealed for the fi rst time how the complex, repetitive ends of chromosomes—regions that normal DNA replication machinery can't cope with—are maintained (1).< I D > J C B 1 8 0 6 p i 1. e p s < / I D > Without telomerase, our chromosomes would shorten increm...
متن کاملIntensive Care: Because you’re worth it?
documentary called 23 Week Babies: the Price of Life. My thoughts and feelings as I watched this programme were not always straightforward. The documentary was moving, sometimes profoundly so. How could it avoid emotional impact when it dealt with life and death, compassion and vulnerability, hope and loss? There were other times when I found myself irritated and frustrated with the presenter a...
متن کاملImaging of parathyroid lesions with radionuclides - Is it worth doing?
Parathyroid adenomas, or hyperplasia may be present in patients with hypercalcemia. Treatment Is by surgical excision, but about 10% of the lesions may be In ectopic locations. Pre-operative localization of the lesions with non-lvasive imaging, using radionuclides, ultrasound, CT, or MR], may simplify surgery, and reduce patient morbidity. However, the reports of the accuracy of the curre...
متن کاملparallel import: is it worth?
one of the most important duties of government in public health sector is to provide secured sources for medicines supply. there are some regulations for domestic pharmaceutical industry. in addition, there is a discipline for importing medicine to be ensured about their claimed characteristics. in medicines registration process, moh (fdo in iran) assess ‘safety’, ‘quality’ and ‘efficacy’ of me...
متن کاملTolerance--is it worth it?
We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cell Biology
سال: 2008
ISSN: 1540-8140,0021-9525
DOI: 10.1083/jcb.1806pi